AAAAAA

   
Results: 1-17 |
Results: 17
Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice
Authors: Perrella, MA Pellacani, A Layne, MD Patel, A Zhao, DZ Schreiber, BM Storch, J Feinberg, MW Hsieh, CM Haber, E Lee, ME
Citation: Ma. Perrella et al., Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice, FASEB J, 15(8), 2001, pp. NIL_450-NIL_465
Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice
Authors: Layne, MD Patel, A Chen, YH Rebel, VI Carvajal, IM Pellacani, A Ith, B Zhao, DZ Schreiber, BM Yet, SF Lee, ME Storch, J Perrella, MA
Citation: Md. Layne et al., Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice, FASEB J, 15(12), 2001, pp. NIL_236-NIL_254
ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene
Authors: Rudders, S Gaspar, J Madore, R Voland, C Grall, F Patel, A Pellacani, A Perrella, MK Libermann, TA Oettgen, P
Citation: S. Rudders et al., ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene, J BIOL CHEM, 276(5), 2001, pp. 3302-3309
Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-beta 1
Authors: Pellacani, A Wiesel, P Razavi, S Vasilj, V Feinberg, MW Chin, MT Reeves, R Perrella, MA
Citation: A. Pellacani et al., Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-beta 1, J BIOL CHEM, 276(2), 2001, pp. 1653-1659
Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice
Authors: Wiesel, P Patel, AP Carvajal, IM Wang, ZY Pellacani, A Maemura, K DiFonzo, N Rennke, HG Layne, MD Yet, SF Lee, ME Perella, MA
Citation: P. Wiesel et al., Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice, CIRCUL RES, 88(10), 2001, pp. 1088-1094
Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1 beta in vascular smooth muscle cells
Authors: Foster, LC Wiesel, P Huggins, GS Panares, R Chin, MT Pellacani, A Perrella, MA
Citation: Lc. Foster et al., Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1 beta in vascular smooth muscle cells, FASEB J, 14(2), 2000, pp. 368-378
Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3
Authors: Werner, F Jain, MK Feinberg, MW Sibinga, NES Pellacani, A Wiesel, P Chin, MT Topper, JN Perrella, MA Lee, ME
Citation: F. Werner et al., Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3, J BIOL CHEM, 275(47), 2000, pp. 36653-36658
Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators
Authors: Wiesel, P Foster, LC Pellacani, A Layne, MD Hsieh, CM Huggins, GS Strauss, P Yet, SF Perrella, MA
Citation: P. Wiesel et al., Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators, J BIOL CHEM, 275(32), 2000, pp. 24840-24846
Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice
Authors: Wiesel, P Patel, AP DiFonzo, N Marria, PB Sim, CU Pellacani, A Maemura, K LeBlanc, BW Marino, K Doerschuk, CM Yet, SF Lee, ME Perrella, MA
Citation: P. Wiesel et al., Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice, CIRCULATION, 102(24), 2000, pp. 3015-3022
Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells
Authors: Pellacani, A Tosi, P Zinzani, P Ottaviani, E Albertini, P Magagnoli, M Tura, S
Citation: A. Pellacani et al., Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells, LEUK LYMPH, 33(1-2), 1999, pp. 147-153
All-trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines
Authors: Visani, G Ottaviani, E Zauli, G Tosi, P Pellacani, A Isidori, A Pierpaoli, S Tura, S
Citation: G. Visani et al., All-trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines, EUR J HAEMA, 63(3), 1999, pp. 149-153
In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells
Authors: Tosi, P Pellacani, A Visani, G Ottaviani, E Ronconi, S Zamagni, E Benni, M Cavo, M Tura, S
Citation: P. Tosi et al., In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells, EUR J HAEMA, 62(3), 1999, pp. 143-148
In vitro study of the combination gemcitabine plus fludarabine on freshly isolated chronic lymphocytic leukemia cells
Authors: Tosi, P Pellacani, A Zinzani, PL Magagnoli, M Visani, G Tura, S
Citation: P. Tosi et al., In vitro study of the combination gemcitabine plus fludarabine on freshly isolated chronic lymphocytic leukemia cells, HAEMATOLOG, 84(9), 1999, pp. 794-798
Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro
Authors: Chin, MT Pellacani, A Hsieh, CM Lin, SSJ Jain, MK Patel, A Huggins, GS Reeves, R Perrella, MA Lee, ME
Citation: Mt. Chin et al., Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro, J MOL CEL C, 31(12), 1999, pp. 2199-2205
Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1 beta in vascular smooth muscle cells - Role in activation of inducible nitric oxide synthase
Authors: Pellacani, A Chin, MT Wiesel, P Ibanez, M Patel, A Yet, SF Hsieh, CM Paulauskis, JD Reeves, R Lee, ME Perrella, MA
Citation: A. Pellacani et al., Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1 beta in vascular smooth muscle cells - Role in activation of inducible nitric oxide synthase, J BIOL CHEM, 274(3), 1999, pp. 1525-1532
High mobility group-I(Y) protein facilitates nuclear factor-kappa B binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer
Authors: Perrella, MA Pellacani, A Wiesel, P Chin, MT Foster, LC Ibanez, M Hsieh, CM Reeves, R Yet, SF Lee, ME
Citation: Ma. Perrella et al., High mobility group-I(Y) protein facilitates nuclear factor-kappa B binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer, J BIOL CHEM, 274(13), 1999, pp. 9045-9052
Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans
Authors: Pellacani, A Fornengo, P Bruno, A Ceruti, C Mioletti, S Curto, M Rinaudo, MT Pagano, G Cavallo-Perin, P
Citation: A. Pellacani et al., Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans, EUR J CL IN, 29(10), 1999, pp. 861-867
Risultati: 1-17 |